Association of signaling proteins with a nonmitogenic heterodimeric complex composed of epidermal growth factor receptor and kinase-inactive p185c-neu

DNA and Cell Biology

Volumn 15, Issue 1, 1996, Pages 31-40

  Dougall, William C ^a,b   Qian, Xiaolan ^a   Miller, Marsha J ^a   Greene, Mark I ^a  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

^b AMGEN INC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EPIDERMAL GROWTH FACTOR RECEPTOR;

ANIMAL CELL; ARTICLE; CELL TRANSFORMATION; COMPLEX FORMATION; HUMAN; MITOGENESIS; NONHUMAN; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN PHOSPHORYLATION; PROTEIN PROTEIN INTERACTION; RAT; SIGNAL TRANSDUCTION;

ANIMALS; CELL LINE; HUMANS; MICE; PHOSPHORYLATION; PROTEIN BINDING; PROTEIN KINASES; PROTEINS; RECEPTOR, EPIDERMAL GROWTH FACTOR; RECEPTOR, ERBB-2; SIGNAL TRANSDUCTION;

ANIMALIA;

EID: 0030026008     PISSN: 10445498     EISSN: None     Source Type: Journal    
DOI: 10.1089/dna.1996.15.31     Document Type: Article

References (14)

1. BARGMANN, C.I., and WEINBERG, R.A. (1988). Oncogenic activation of the new-encoded receptor protein by point mutation and deletion. EMBO J. 7, 2043-2052.
2. BEN-LEVY, R., PATERSON, H.F., MARSHALL, C.J., and YARDEN, Y. (1994). A single autophosphorylation site confers oncogcnicity to the Neu/ErbB-2 receptor and enables coupling to the MAP kinase pathway. EMBO J. 13, 3302-3311.
3. CAMPOS-GONZALES, R., and GLENNEY, J.R. (1992). Tyrosine phosphorylation of mitogen-activated protein kinase in cells with tyrosine kinase-negative epidermal growth factor receptors. J. Biol. Chem. 267, 14535-14538.
4. CARRAWAY, K.L., and CANTLEY, L. (1994). A neu acquaintance for erbB3 and erbB4: A role for receptor heterodimerization in growth signaling. Cell 78, 5-8.
5. CHAZIN, V.R., M. KALEKO, et al. (1992). Transfection mediated by the human Her-2 gene independent of the epidermal growth factor receptor. Oncogene 7, 1859-1866.
6. DI GUGLIEMO, G.M., BAASS, P., OU, W.J., POSNER, B.I., and BERGERON, J.J. (1994). Compartmentalization of SHC, GRB2 and mSOS, and hyperphosphorylation of Raf-1 by EGF but not insulin in liver parenchyma. EMBO J. 13, 3302-3311.
7. DI FIORE, P.P., PIERCE, J.H., et al. (1987). erbB-2 is a potent oncogene when overexpressed in NIH/3T3 cells. Science 237, 178-182.
8. DI FIORE, P., SEGATTO, O., et al. (1990). The carboxy-terminal domains of erbB-2 and epidermal growth factor receptor exert different regulatory effects on intrinsic receptor tyrosine kinase function and transforming activity. Mol. Cell. Biol. 10, 2749-2756.
9. DOUGALL, W.C., QIAN, X., PETERSON, N.C., MILLER, M.J., SAMANTA, A., and GREENE, M.I. (1994). The neu-oncogene: signal transduction pathways, transformation mechanisms and evolving therapies. Oncogene 9, 2109-2123.
10. DREBIN, J., STERN, D., et al. (1984). Monoclonal antibodies identify a cell-surface antigen associated with an activated cellular oncogene. Nature 312, 545-548.
11. EGAN, S.E., GIDDINGS, B., BROOKS, M., BUDAY, L., SEELAND, A., and WEINBERG, R.A. (1993). Association of Sos Ras exchange protein with Grb2 is implicated in tyrosine kinase signal transduction and transformation [see comments]. Nature 363, 45-51.
12. ELLIS, C., MORAN, M., et al. (1990). Phosphorylation of GAP and GAP-associated proteins by transforming and mitogenic tyrosine kinases. Nature 343, 377-381.
13. FAZIOLI, F., KIM, U.K., et al. (1991). The erbB-2 mitogenic signaling pathway-Tyrosine phosphorylation of phospholipase-C-gamma and GTPase-activating protein does not correlate with erbB-2 mitogenic potency. Mol. Cell. Biol. 11, 2040-2048.
14. FAZIOLI, F., BOTTARO, D.P., et al. (1992). Identification and biochemical characterization of novel putative substrates for the epidermal growth factor receptor kinase. J. Biol. Chem. 267, 5155-5161.